ncomms10044.pdf (2.27 MB)
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
journal contribution
posted on 2023-06-09, 13:47 authored by Van T M Nguyen, Iros Barozzi, Monica Faronato, Ylenia Lombardo, Jennifer H Steel, Naina Patel, Philippa Darbre, Leandro CastellanoLeandro Castellano, Balázs Gyorffy, Laura Woodley, Alba Meira, Darren K Patten, Valentina Vircillo, Manikandan Periyasamy, Simak Ali, Gianmaria Frige, Saverio Minucci, R Charles Coombes, Luca MagnaniEndocrine therapies target the activation of the oestrogen receptor alpha (ERa) via distinct mechanisms, but it is not clear whether breast cancer cells can adapt to treatment using drug-specific mechanisms. Here we demonstrate that resistance emerges via drug-specific epigenetic reprogramming. Resistant cells display a spectrum of phenotypical changes with invasive phenotypes evolving in lines resistant to the aromatase inhibitor (AI). Orthogonal genomics analysis of reprogrammed regulatory regions identifies individual drug-induced epigenetic states involving large topologically associating domains (TADs) and the activation of super-enhancers. AI-resistant cells activate endogenous cholesterol biosynthesis (CB) through stable epigenetic activation in vitro and in vivo. Mechanistically, CB sparks the constitutive activation of oestrogen receptors alpha (ERa) in AI-resistant cells, partly via the biosynthesis of 27-hydroxycholesterol. By targeting CB using statins, ERa binding is reduced and cell invasion is prevented. Epigenomic-led stratification can predict resistance to AI in a subset of ERa-positive patients.
History
Publication status
- Published
File Version
- Published version
Journal
Nature CommunicationsISSN
2041-1723Publisher
Nature ResearchExternal DOI
Issue
10044Volume
6Department affiliated with
- Biochemistry Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2018-06-15First Open Access (FOA) Date
2018-06-15First Compliant Deposit (FCD) Date
2018-06-15Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC